Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
Main Authors: | Rita Calça, Cristina Jorge, Luís Lebre, Eunice Cacheira, Sara Querido, Célia Nascimento, Teresa Adragão, Margarida Bruges, André Weigert, Domingos Machado |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Nefrología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251420301334 |
Similar Items
-
Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
by: Rita Calça, et al.
Published: (2020-11-01) -
HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
by: AR Fernandes, et al.
Published: (2017-04-01) -
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
by: Ming V Lin, et al.
Published: (2016-01-01) -
Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
by: Paolo Carta, et al.
Published: (2020-05-01) -
Outcomes of Living Kidney Donor Candidates and Living Kidney Recipient Candidates with JC Polyomavirus and BK Polyomavirus Viruria
by: Sara Querido, et al.
Published: (2021-01-01)